Literature DB >> 25877953

Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer.

Carlos K H Wong1, Edmond P H Choi2, James H L Tsu3, Brian S H Ho3, Ada T L Ng3, W Y Chin2, M K Yiu3.   

Abstract

PURPOSE: The aim of the study was to assess the validity, reliability and sensitivity of the FACT-P (version 4) in Chinese males with prostate cancer.
METHODS: Construct validity was assessed using Spearman's correlation test against the 12-item Short Form Health Survey (SF-12v2). Internal consistency and test-retest reliability were assessed using Cronbach's α coefficient and intra-class correlation coefficient, respectively. Sensitivity was determined by performing known-group comparisons by independent t test.
RESULTS: FACT-P subscale scores had a moderate correlation with the corresponding SF-12v2 domain score that conceptually measures the similar construct providing evidence for adequate construct validity. Internal consistency was acceptable (α: 0.687-0.900) for all subscales aside from the Prostate Cancer Subscale (α: 0.505) and Trial Outcome Index (α: 0.562). FACT-P subscale and total scores showed good test-retest reliability (range 0.753-0.913). All total scales and most of the subscales were sensitive in detecting differences between patients with different levels of functional impairment but not different cancer stages or levels of prostate-specific antigen.
CONCLUSIONS: The measure is a valid and reliable measure to assess the health-related quality of life of Chinese males with prostate cancer. The FACT-P is sensitive to detect difference between patients with varying functional status.

Entities:  

Keywords:  Chinese; Prostate cancer; Psychometrics; Quality of life; Reliability; Validity

Mesh:

Year:  2015        PMID: 25877953     DOI: 10.1007/s11136-015-0993-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  Is the standard SF-12 health survey valid and equivalent for a Chinese population?

Authors:  Cindy L K Lam; Eileen Y Y Tse; Barbara Gandek
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

2.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

3.  Validity and reliability of the FACT-G scale for use in the older person with cancer.

Authors:  J Overcash; M Extermann; J Parr; J Perry; L Balducci
Journal:  Am J Clin Oncol       Date:  2001-12       Impact factor: 2.339

Review 4.  Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.

Authors:  Thomas W Storer; Renee Miciek; Thomas G Travison
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

5.  Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample.

Authors:  P Winstead-Fry; A Schultz
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

6.  Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

Authors:  P Esper; F Mo; G Chodak; M Sinner; D Cella; K J Pienta
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

7.  Quality of life in adult survivors of lung, colon and prostate cancer.

Authors:  C A Schag; P A Ganz; D S Wing; M S Sim; J J Lee
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

8.  Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer.

Authors:  P Esper; J N Hampton; D C Smith; K J Pienta
Journal:  Oncol Nurs Forum       Date:  1999 Jan-Feb       Impact factor: 2.172

9.  Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.

Authors:  Stefanie Schmidt; Olatz Garin; Yolanda Pardo; José M Valderas; Jordi Alonso; Pablo Rebollo; Luis Rajmil; Carlos Garcia-Forero; Montse Ferrer
Journal:  Qual Life Res       Date:  2014-04-19       Impact factor: 4.147

10.  Validation of the functional assessment of cancer therapy-gastric module for the Chinese population.

Authors:  Hui Jun Zhou; Jimmy B Y So; Wei Peng Yong; Nan Luo; Feng Zhu; Nasheen Naidoo; Shu Chuen Li; Khay Guan Yeoh
Journal:  Health Qual Life Outcomes       Date:  2012-11-30       Impact factor: 3.186

View more
  4 in total

1.  The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer.

Authors:  Edmond P H Choi; Carlos K H Wong; Eric Y F Wan; James H L Tsu; W Y Chin; Kenny Kung; M K Yiu
Journal:  Qual Life Res       Date:  2016-02-23       Impact factor: 4.147

2.  Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations.

Authors:  Edmond P H Choi; Carlos K H Wong; James H L Tsu; W Y Chin; Kenny Kung; Charles K W Wong; M K Yiu
Journal:  Support Care Cancer       Date:  2015-10-09       Impact factor: 3.603

3.  Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China.

Authors:  Dingwei Ye; Wei Zhang; Lulin Ma; Chuanjun Du; Liping Xie; Yiran Huang; Qiang Wei; Zhangqun Ye; Yanqun Na
Journal:  Chin J Cancer Res       Date:  2019-06       Impact factor: 5.087

4.  Symptoms predicting health-related quality of life in prostate cancer patients treated with localized radiation therapy.

Authors:  Chao-Pin Hsiao; Mea-Kuang Chen; Kathy J Meyers; Leorey N Saligan
Journal:  Fam Med Community Health       Date:  2017-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.